Big-Pharma Seeks Monopoly Over Life-Changing Therapy

By dangling life-changing cures over people's heads for cartoonish figures of "1 million dollars," pharmaceutical corporations prove when they see sick, desperate, dying people, all they see is dollar signs... 

November 12, 2015 (Tony Cartalucci - LocalOrg) - Gene therapy is a game changer. It is not a treatment for diseases. It is a cure.

Image: Gene therapy works by reprogramming an ordinary virus to delivery modified genes to human cells. Once introduced, the modified genes are replicated by natural cell division. Missing or defective genes, over time, can be replaced by repaired genes, reprogramming the immune system to eradicate otherwise incurable diseases, or creating function in defective systems, curing blindness, deafness, diabetes, and even effects owed to aging. 

It is a cure for cancer, genetic defects, blindness, deafness, diabetes, even potentially aging.

It has already proven effective in clinical trials, curing people of leukemia who were otherwise certain to die, giving people their sight back, and already, there is one therapy approved for use in the European Union with several others approved in China.

The most remarkable aspect of gene therapy is that it overwrites your DNA once, then your cells replicate that new DNA each time they divide. In essence, the cure becomes a permanent part of you. One shot, one cure, for life, or close to it.

Why Haven't We Heard More About This? 

As remarkable and as promising as gene therapy is, it poses an immense threat to the established healthcare industry. A shot in clinical trials using experimental equipment that costs only 20,000 USD to produce that cures leukemia, if brought into mainstream medicine would be cheaper still, and undercut existing and ineffective"treatments" that can reach costs in the hundreds of thousands of dollars.

Gene therapy, then, is essentially a disruptive technology that brings various healthcare rackets to an abrupt halt along with all the vast wealth and unwarranted power and influence big-pharma has enjoyed over the decades.

Image: Dr. Carl June (center) led a team that developed a breakthrough gene therapy that effectively reprograms the immune system to hunt and kill leukemia cancer cells. Most of the patients, otherwise sure to die from their cancer, have gone into permanent remission. 

How can big-pharma continue on with its monopolies, wealth, and influence by curing everyone with one shot that costs almost nothing to make?

Their strategy is two-fold. First, they have intentionally dragged their feet for as long as possible until they can figure this problem out, letting people die of now curable diseases simply because they want to protect their existing business models and bottom lines.

Second, they have begun to mold public opinion through intense lobbying across the media and medical journals, ignoring the actual costs involved in producing the therapies, and instead cashing in on what they think it is worth to people, or in other words, dangling cures for crippling, deadly diseases over dying and/or desperate people's heads, and seeing how much they are willing to pay for them.

The Dangers of Human Gene Editing

June 6, 2015 (Ulson Gunnar - NEO) - It is often said that if it can be imagined, it will inevitably be done. And such a sentiment could not be any truer in terms of applying genetic engineering and synthetic biology to the genomes of our planet's organisms including humans themselves.

While the process of synthesizing and arranging genetic code has many processes, perhaps none has been as promising as the CRISPR-Cas system. From laboratory experiments to emerging software used to create code genetically almost as easily as code for a computer, gene editing has never been easier, opening the door to never-before-possible applications.

Perhaps no technology yet has been poised to change the world so profoundly. All life on Earth, every living organism, now stands the possibility of potentially being "edited" on the most basic genetic level, enhancing or degrading it, but forever changing it.

Gene editing or "gene therapy" performed on children or adults changes the genetic makeup of targeted cells after which and upon dividing, impart this new genetic material on each subsequent new cell. This is why treatments for diseases using gene therapy often are successful with only a single shot. The "treatment" self-replicates perpetually within the patient's body. Everything from leukemia to congenial genetic defects have been overcome in clinical trials using this method.

As far as science knows, these changes cannot be passed onto the offspring of patients. However, changing the genetic makeup of a human at their earliest stages of development can be passed on, spreading genetic changes made in labs onto the greater population. 

The Information War on a Whole New Level: Space

April 15, 2015 (Ulson Gunnar - NEO) - The information war can be quickly lost if one cannot get their assets onto the "battlefield." For the US, UK or Europe, the constant din of their propaganda spread across the planet via their impressive and immense media networks has recently run into a few snags.

In nations like Russia, China or Iran, ruling governments and local industry have begun creating their own Internets, their own alternatives to US-controlled social media platforms and search engines, and in some cases, even their own hardware to run it all on. They have also taken a cue from the US and decided to put in "kill switches" and censorship measures to prevent information from abroad being piped into their nation and disseminated among their populations.

Or more accurate than saying "to prevent information from abroad," one could say, "propaganda from abroad."

For instance, the US State Department's Voice of America network openly attempts to insert narratives favorable to US interests in targeted countries. So important does the US State Department see this mission, it has even attempted to construct independent communication networks by building their own towers and relay stations.